These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 7710929
1. Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines. Sark MW, Timmer-Bosscha H, Meijer C, Uges DR, Sluiter WJ, Peters WH, Mulder NH, de Vries EG. Br J Cancer; 1995 Apr; 71(4):684-90. PubMed ID: 7710929 [Abstract] [Full Text] [Related]
2. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro. Dempke WC, Shellard SA, Hosking LK, Fichtinger-Schepman AM, Hill BT. Carcinogenesis; 1992 Jul; 13(7):1209-15. PubMed ID: 1638688 [Abstract] [Full Text] [Related]
3. JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatin. Fokkema E, Groen HJ, Helder MN, de Vries EG, Meijer C. Biochem Pharmacol; 2002 Jun 01; 63(11):1989-96. PubMed ID: 12093475 [Abstract] [Full Text] [Related]
7. A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase II activity. Barret JM, Calsou P, Larsen AK, Salles B. Mol Pharmacol; 1994 Sep 01; 46(3):431-6. PubMed ID: 7935322 [Abstract] [Full Text] [Related]
8. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Kasahara K, Fujiwara Y, Nishio K, Ohmori T, Sugimoto Y, Komiya K, Matsuda T, Saijo N. Cancer Res; 1991 Jun 15; 51(12):3237-42. PubMed ID: 1645616 [Abstract] [Full Text] [Related]
9. Determinants of cisplatin and irinotecan activities in human lung adenocarcinoma cells: evidence of cisplatin accumulation and topoisomerase I activity. Matsumura T, Takigawa N, Kiura K, Shibayama T, Chikamori M, Tabata M, Ueoka H, Tanimoto M. In Vivo; 2005 Jun 15; 19(4):717-21. PubMed ID: 15999539 [Abstract] [Full Text] [Related]
11. Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line. Singh SV, Xu BH, Jani JP, Emerson EO, Backes MG, Rihn C, Scalamogna D, Stemmler N, Specht S, Blanock K. Int J Cancer; 1995 May 04; 61(3):431-6. PubMed ID: 7729958 [Abstract] [Full Text] [Related]
19. Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptor. Nishikawa K, Rosenblum MG, Newman RA, Pandita TK, Hittelman WN, Donato NJ. Cancer Res; 1992 Sep 01; 52(17):4758-65. PubMed ID: 1380890 [Abstract] [Full Text] [Related]
20. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines. Mistry P, Kelland LR, Abel G, Sidhar S, Harrap KR. Br J Cancer; 1991 Aug 01; 64(2):215-20. PubMed ID: 1892748 [Abstract] [Full Text] [Related] Page: [Next] [New Search]